Ebitda Veränderung Datum
Akzo Nobel EUR 388M 10M 2026-09
Alcon AG USD 795M 478M 2026-03
AstraZeneca USD 7.46B 2.3B 2026-09
Bayer EUR 1.62B 529M 2026-09
Beiersdorf EUR 926M 58M 2026-06
DaVita Healthcare Partners USD 664.44M 82.37M 2026-09
Demant DKK 2.8B 47M 2026-06
E.ON EUR 2.15B 2.97B 2026-06
Essilor EUR 4.34B 1.25B 2026-06
Fresenius EUR 988M 37M 2026-06
Fresenius Medical Care EUR 817M 26.66M 2026-09
Genmab DKK 401M 186M 2026-06
Getinge SEK 1.89B 1.58B 2026-06
Givaudan CHF 778M 195M 2025-12
GlaxoSmithKline GBP 3.51B 734M 2026-06
GN Store Nord DKK 352M 139M 2026-06
GRIFOLS EUR 473M 120M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.6B 69M 2026-06
Novartis USD 8.62B 2.14B 2026-09
Philips EUR 772M 138M 2026-09
Roche Holding CHF 13.43B 744M 2026-06
RWE EUR 1.38B 251M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
SAP EUR 3.36B 1000K 2026-09
Smith & Nephew USD 796M 139M 2025-12